Skip to content
Screener

Design Therapeutics, Inc. DSGN Other Non-Current Assets

Other Non-Current Assets at other companies

ALN
Alnylam PharmaceuticalsALNY
$65.13M+13.9%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$37.73M-53.0%
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$28.98M+39.5%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$31K-44.6%
Taysha Gene Therapies, Inc. logo
Taysha Gene Therapies, Inc.TSHA
$106K-43.0%
Vor Biopharma logo
Vor BiopharmaVOR
$2.41M+1.6%

Other financials

Income statement

See full
Revenue-
Operating income-$19.7M+3.5%
Net income-$17.6M+0.4%
EPS (diluted)-$0.29+6.5%

Balance sheet

See full
Cash & equivalents$12.8M-6.6%
Total debt$2.7M+27.7%
Total equity$218.1M-4.3%
Total assets$230.4M-3.0%

Cash flow

See full
Operating cash flow-$16.4M+2.1%
CapEx--100%
Free cash flow-$16.4M+2.6%

Valuation

See full
Market cap$875.52M+219%
Enterprise value$865.48M+237%

Profitability

See full
Operating margin-3,685.8%
Net margin-3,663.7%

Returns & leverage

See full
Return on equity-31.3%+19.5pp
Debt / equity0.0×
Current ratio22.3×-6.1×

Where this comes from

Reported directly by Design Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssets.

The source filing: Design Therapeutics, Inc.’s 10-K, filed March 9, 2026.

Filed
Mar 9, 2026, 4:08 PM EDT
Fiscal year
FY2025
Accession
0001193125-26-098491
Line itemDecember 31, 2025December 31, 2024
Total current assets223,784248,040
Property and equipment, net9811,410
Right-of-use asset, related party1,4382,216
Other assets427
Total assets$226,203$252,093
Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable$2,312$2,186

Item 8. Financial Statements and Supplementary Data.

FAQ

What is Design Therapeutics, Inc.'s other non-current assets?
Design Therapeutics, Inc. (DSGN) reported other non-current assets of $0 in Q4 2025.
How has Design Therapeutics, Inc.'s other non-current assets changed year-over-year?
Design Therapeutics, Inc.'s other non-current assets decreased by 100.0% year-over-year, from $427K to $0.
What is the long-term trend for Design Therapeutics, Inc.'s other non-current assets?
Over 3 years (2022 to 2025), Design Therapeutics, Inc.'s other non-current assets has grown at a -100.0% compound annual growth rate (CAGR), from $459K to $0.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Design Therapeutics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude